Position in NVS
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$35,465,892
New position
Shares Held
226,301
first reported quarter
Ownership
0.012%
of shares outstanding
% of Portfolio
4.35%
of 13F equity value
Holder Rank
#79
of 1,603 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026TriCert Investment Counsel Inc. holds $105,978,951 across 4 Drug Manufacturers - General names. NVS ranks #2 (33.5% of the industry book) .
All Filings in NVS
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $35,465,892 | 226,301 | Shares | Sole | 2026-08-10 | |
| No filing history on record for this holder in this stock. | ||||||